| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/17/2011 | WO2011019685A2 Second generation fatty acid compositions, formulations, and methods of use and synthesis thereof |
| 02/17/2011 | WO2011019323A1 Particulate hyaluronic acid formulations for cellular delivery of bioactive agents |
| 02/17/2011 | WO2011019317A1 Compositions and methods for treating fungal infection of the nail |
| 02/17/2011 | WO2011019046A1 Disintegrating particle composition and orally rapidly disintegrating tablet |
| 02/17/2011 | WO2011019045A1 Disintegrating particle composition and orally rapidly disintegrating tablet |
| 02/17/2011 | WO2011019043A1 Tablet that disintegrates rapidly in the mouth and that contains two or more types of particles |
| 02/17/2011 | WO2011018858A1 Novel mastitis vaccine |
| 02/17/2011 | WO2011018583A2 Novel pharmaceutical formulations against drug misuse |
| 02/17/2011 | WO2011018480A1 Pharmaceutical composition including a dha ester to be parenterally administered |
| 02/17/2011 | WO2011017835A1 Preparation method of protein or peptide nanoparticles for in vivo drug delivery by unfolding and refolding |
| 02/17/2011 | WO2010118339A3 Formulations of indole-3-carbinol derived antitumor agents with increased oral bioavailability |
| 02/17/2011 | WO2010111565A3 Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish |
| 02/17/2011 | WO2010084169A3 Fgf21 derivatives with albumin binder a-b-c-d-e- and their use |
| 02/17/2011 | WO2010042701A3 Corticosteroid compositions for use in treating diseases of the upper and lower airway passages |
| 02/17/2011 | WO2010007604A3 Inhalable microparticles, and methods for the production thereof |
| 02/17/2011 | US20110040057 Ligand-coupled initiator polymers and methods of use |
| 02/17/2011 | US20110039950 Alkyl and/or Alkenyl Ethers of Alkyl and/or Alkenyl (Poly)Glycosides and Their Use |
| 02/17/2011 | US20110039949 Pet food product and method of manufacture |
| 02/17/2011 | US20110039947 Surface-modified nanoparticles |
| 02/17/2011 | US20110039929 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| 02/17/2011 | US20110039924 Alpha-amino acid derivatives for improving solubility |
| 02/17/2011 | US20110039876 Solution formulations of sirolimus and its analogs for cad treatment |
| 02/17/2011 | US20110039800 Prolonged release bioadhesive therapeutic systems |
| 02/17/2011 | US20110038953 Strontium compound for treatment of sub-dermal soft tissue pain |
| 02/17/2011 | US20110038942 Beta-lactoglobulin-polysaccharide nanoparticles for hydrophobic bioactive compounds |
| 02/17/2011 | US20110038938 Compositions for tissue augmentation |
| 02/17/2011 | US20110038926 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 02/17/2011 | US20110038918 Composition For Transdermal Delivery of Fentanyl |
| 02/17/2011 | US20110038913 Polymeric endoprostheses with modified erosion rates and methods of manufacture |
| 02/17/2011 | US20110038896 Biodegradable immunomodulatory formulations and methods for use thereof |
| 02/17/2011 | US20110038888 Adjuvant compositions comprising poly-ic and a cationic polymer |
| 02/17/2011 | US20110038864 Antibodies Against Cancer Antigen TMEFF2 and Uses Thereof |
| 02/17/2011 | US20110038828 Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same |
| 02/17/2011 | DE102009035211A1 Copräzipitate umfassend einen Phosphodiesterase-5-Inhibitor (PDE-5-Inhibitor) und einen pharmazeutisch verträglichen Trägerstoff, ihre Herstellung und Verwendung Coprecipitates comprising a phosphodiesterase-5 inhibitor (PDE-5) inhibitor and a pharmaceutically acceptable carrier, their preparation and use |
| 02/17/2011 | CA2804755A1 Modified vasoactive intestinal peptides |
| 02/17/2011 | CA2771297A1 Methods of treating cancer using neurotrophin retargeted endopeptidases |
| 02/17/2011 | CA2771164A1 Methods of treating cancer using tachykinin retargeted endopeptidases |
| 02/17/2011 | CA2771054A1 Novel pharmaceutical formulations against drug misuse |
| 02/17/2011 | CA2770737A1 Antibodies against human respiratory syncytial virus (rsv) and methods of use |
| 02/17/2011 | CA2770262A1 Pharmaceutical composition including a dha ester to be parenterally administered |
| 02/17/2011 | CA2770240A1 Peptide libraries |
| 02/17/2011 | CA2768965A1 Use of il-15 to increase thymic output and to treat lymphopenia |
| 02/17/2011 | CA2764236A1 Compositions and methods for treating fungal infection of the nail |
| 02/16/2011 | EP2284209A1 Polymer conjugate of folic acid or folic acid derivative |
| 02/16/2011 | EP2284180A2 Peptides that specifically bind HGF receptor (CMET) and uses thereof |
| 02/16/2011 | EP2283897A2 HSA-free formulations of interferon-beta |
| 02/16/2011 | EP2283896A2 HSA-free formulations of interferon-beta |
| 02/16/2011 | EP2283869A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |
| 02/16/2011 | EP2283868A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |
| 02/16/2011 | EP2283867A2 Methods of treatment using anti-ERBB antibody-maytansinoid conjugates |
| 02/16/2011 | EP2283866A2 Methods of treatment using anti-ERBB antibody-maytansinoid conjugates |
| 02/16/2011 | EP2283865A1 Method of increasing testosterone and related steroid concentrations in women |
| 02/16/2011 | EP2283864A1 Liquid dosage compositions fo stable nanoparticulate active agents |
| 02/16/2011 | EP2283856A1 Stabilised solid compositions of factor VII polypeptides |
| 02/16/2011 | EP2283845A1 Sustained release drug delivery system containing codrugs |
| 02/16/2011 | EP2283842A1 Tamper-resitant oral opioid agonist formulations |
| 02/16/2011 | EP2283821A1 Preparation of biodegradable microparticles containing a biologically active agent |
| 02/16/2011 | EP2283820A1 Residual solvent extraction method and microparticles produced thereby |
| 02/16/2011 | EP2283816A1 Melt-extruded orally administrable opioid formulations |
| 02/16/2011 | EP2283809A1 Microneedle array using porous substrate and process for producing same |
| 02/16/2011 | EP2283358A2 Immunomodulating compositions and methods of use thereof |
| 02/16/2011 | EP2283123A1 Inhibitors of bacterial tyrosine kinase and uses thereof |
| 02/16/2011 | EP2283027A2 Protein formulation |
| 02/16/2011 | EP2282775A2 Vector for use in medicine |
| 02/16/2011 | EP2282741A2 Treating eosinophilic esophagitis |
| 02/16/2011 | EP2282740A1 Antifolate compositions |
| 02/16/2011 | EP2282737A2 Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone |
| 02/16/2011 | EP2061433B1 Compositions for enhancing transport through mucus |
| 02/16/2011 | EP1944354B1 Flavor composition or fragrance composition, and flavor-improving agent |
| 02/16/2011 | EP1450763B1 Agent for treating excess weight in association with other indications |
| 02/16/2011 | CN1994385B Externally applied Chinese medicinal effervescence tablet for fumigating and washing to treat external piles and anal fissure and method for preparing same |
| 02/16/2011 | CN101977634A Method for the synthesis of hollow spheres |
| 02/16/2011 | CN101977631A Polymer conjugate of physiologically active substance |
| 02/16/2011 | CN101977630A Ophthalmic composition |
| 02/16/2011 | CN101977629A Therapeutic agent for fibroid lung |
| 02/16/2011 | CN101977598A Water-based adhesive skin patch comprising ketoprofen lysine salt |
| 02/16/2011 | CN101977597A Methods of inhibiting bacterial virulence and compounds relating thereto |
| 02/16/2011 | CN101977591A Phosphate buffered ophthalmic solutions displaying improved efficacy |
| 02/16/2011 | CN101977590A Ophthalmic solutions displaying improved efficacy |
| 02/16/2011 | CN101977589A Chitosan gel for dermatological use, production method therefor and use of same |
| 02/16/2011 | CN101974229A Polylactic acid-polyethylene glycol/europium doped calcium phosphate nano composite material, modified substance thereof and preparation of both |
| 02/16/2011 | CN101974152A Lipoid-cation polymer and preparation method thereof |
| 02/16/2011 | CN101974150A Ibuprofen end group-containing polyethylene glycol medicine macromonomer and synthesis method thereof |
| 02/16/2011 | CN101974138A Method for preparing amphiphilic gradient copolymer |
| 02/16/2011 | CN101974137A Polyethylene glycol momomethyl ether-polycaprolactone-polyacrylic acid derivatives, and preparation and application thereof |
| 02/16/2011 | CN101974090A GLP-1 analog fusion proteins |
| 02/16/2011 | CN101974089A Recombination fusion protein Trx-TAT-hMsrA and application thereof to aspect of nerve cell protection |
| 02/16/2011 | CN101972493A Visualized iodized oil-5-fluorouracil loaded polylactic acid microsphere preparation and preparation method thereof |
| 02/16/2011 | CN101972481A Macromolecular microcarrier and preparation method thereof |
| 02/16/2011 | CN101972480A Docetaxel polymeric micelle medicine composition taking amino acid as stabilizing agent |
| 02/16/2011 | CN101972479A Preparation process of intravenous injection human immunoglobulin |
| 02/16/2011 | CN101972470A In-situ gel composition for eyes |
| 02/16/2011 | CN101972451A Compound infusion preparation of Chinese herbal medicines and western medicines for treating cow hysteritis and preparation method thereof |
| 02/16/2011 | CN101972395A Calming and decompressing traditional Chinese medicine composition and preparation method thereof |
| 02/16/2011 | CN101972376A Chinese medicinal ointment for treating intervertebral disc hyperosteogeny and preparation method thereof |
| 02/16/2011 | CN101972293A Externally-applied paste for treating rheumatoid bone join pain and operating method thereof |
| 02/16/2011 | CN101972282A Method for preparing substrate for Chinese medicinal microemulsion paste patch |
| 02/16/2011 | CN101972276A Transdermal drug delivery system for treating infantile diarrhea and preparation method thereof |
| 02/16/2011 | CN101972272A Chlorine dioxide skin gel and preparation method thereof |
| 02/16/2011 | CN101972271A Chlorine dioxide mucous membrane gel and preparation method thereof |